stockrowMaravai LifeSciences Holdings, Inc. (MRVI) vs Stoke Therapeutics, Inc. (STOK)
- Maravai LifeSciences Holdings, Inc. MRVI 7.52 +7.74%
- Stoke Therapeutics, Inc. STOK 26.54 +1.80%
Maravai LifeSciences Holdings, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.8B and $1.7B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: 10.7% against −86.3%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−30.8% vs −862.1%) and the higher return on invested capital (−13.6% vs −482.0%). Across the 17 metrics below, Maravai LifeSciences Holdings, Inc. leads on 13 and Stoke Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | MRVI | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 39.15% | 100.00% | 68.51% |
| Operating margin | (45.38%) | (913.12%) | 0.00% |
| Net margin | (30.83%) | (862.07%) | 0.00% |
| Free cash flow margin | (5.89%) | (764.66%) | 0.00% |
| Return on equity | (17.01%) | (73.62%) | (51.96%) |
| Return on assets | (9.06%) | (63.42%) | (46.06%) |
| Return on invested capital | (13.62%) | (482.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack